Long-term Renal Prognosis of Neonatal Acute Kidney Injury

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 28
SponsorGuangzhou Women and Children's Medical Center

About this trial

The goal of this observational study is to conduct a multicenter, prospective neonatal acute kidney injury (AKI) follow-up cohort to describe the clinical characteristics of chronic kidney disease (CKD) in AKI cases within 1 year of follow-up and screen for effective biomarkers that can early warn of CKD progression. Ultimately, a neonatal AKI adverse prognosis warning model based on multidimensional data will be established to provide new data and new models for CKD management.

Eligibility criteria

Qualifiers

Delivered in this hospital and subsequently admitted to the NICU during the study period;

Diagnosed with neonatal AKI according to the 2015 KDIGO neonatal AKI criteria;

Age <28 days.

Disqualifiers

Severe hydronephrosis diagnosed by prenatal renal ultrasound;

Patients with congenital urinary malformations, including solitary kidney, cystic dysplasia, multicystic dysplastic kidney, renal dysplasia, and obstructive uropathy;

Newborns who required congenital heart surgery within the first 7 days after birth;

Newborns whose mothers had a history of renal failure;

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

This trial has no locations